miRagen Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, has hired Lee Rauch as the new Chief Operating Officer. Rauch joins miRagen from Columbia Technology Ventures, where she served as the Executive in Residence. Prior to Columbia Tech Ventures, Rauch served as Managing Director at Cervantes Life Science Partners.
The search was successfully led by Michael Cane for Westwood & Wilshire’s Life Sciences practice.
At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.
Westwood & Wilshire, LLC
Offices in Los Angeles, Silicon Valley, Seattle, and Scottsdale
© Westwood & Wilshire LLC. All Rights Reserved.